PP/PE/PVC wall corrugated pipe extrusion machine zhangjiagang sevenstars machinery co.,ltd , https://www.sevenstars-machineries.com
The Jin Ganning capsule included in the “National Torch Program Key Project†was jointly developed by Pixian Pien Tze Huang Pharmaceutical and the Chinese Academy of Medical Sciences Institute of Pharmaceutical Research. Jin Ganning capsule is a natural glycosidase inhibitor extracted from natural Chinese herbal medicine through modern pharmaceutical technology and concentrated in effective ingredients. It has independent intellectual property rights in China. The hypoglycemic active ingredient is the newly discovered deoxynojirimycin in the pharmaceutical industry in the U.S. and Japan, which can effectively inhibit the activity of glycosidase in the small intestine, reduce and delay the absorption of monosaccharides in the food into the blood through the small intestine, and reduce postprandial blood glucose levels. Improve dyslipidemia in the course of diabetes. The effect of JinGanNing capsules is more specific and it is an effective postprandial blood glucose control drug. Studies have confirmed that Jin Ganning capsule not only has the exact hypoglycemic effect of common western medicine hypoglycemic agents, but also reduces the risk of drugs causing hypoglycemia and gastrointestinal disorders. Clinical studies have also confirmed that Jin Ging Ning capsules have the effect of regulating dyslipidemia and protecting blood vessels while regulating blood glucose, which can reduce the risk of diabetic complications.
The advent of JinGanNing capsules is a leap in postprandial blood glucose control medicines from chemical synthesis to pure natural extraction. It not only breaks through the limitations of traditional Chinese medicine hypoglycemic mechanism, but also surpasses the effect of a single type of chemical hypoglycemic drugs. .
Chinese medicine Jin Ganning capsules with independent intellectual property rights are approved for listing
The traditional Chinese medicine hypoglycemic agent Jintanging Capsule, which has independent intellectual property rights in China and can effectively control postprandial blood glucose, has recently received a new drug certificate issued by the State Food and Drug Administration.